Testing effectiveness (Phase 2)Looking for participantsNCT06846463
What this trial is testing
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Who this might be right for
Diffuse Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Virginia Commonwealth University 21